Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/90.BMDkfsfZ.js ...

Salesforce (NYSE:CRM) is set to report fiscal third-quarter results tomorrow after the close of trading, and Wedbush ...

Shares of Snowflake ( SNOW) gained about 3% Monday afternoon as Wedbush upgraded the stock, saying the cloud software ...

The billionaire was panned for overspending on Twitter, but the platform is winning him favor with Donald Trump and ...

Investing.com -- Wedbush analysts expect tech stocks to end the year on a positive note with a “Santa rally,” citing positive catalysts including deregulation under Donald Trump’s second term and ...

Salesforce (CRM) is expected to report strong fiscal third-quarter results this week amid elevated use cases for its entire product portfolio and demand for artificial intelligence solutions, ...

Customer relationship software provider Salesforce. Inc. ($CRM) is scheduled to release its fiscal year 2025 third-quarter ...

Major technology stocks are positioned for a strong year-end rally as artificial intelligence initiatives accelerate and ...

Wedbush upgraded Voyager Therapeutics (VYGR) to Outperform from Neutral with a price target of $11, up from $7, after ...

Tesla’s strategic pivot toward AI and autonomy reinforces its position as a leading disruptive technology company, not merely an automaker, the analysts said. Investors are closely watching regulatory ...

Tavares' sudden departure caps a series of problems this year for the automaker, especially in the United States.

Wedbush has assumed coverage of Voyager Therapeutics (NASDAQ:VYGR) with an outperform rating, highlighting the company’s TRACER platform. The investment firm said it believes TRACER alone should ...